KR102456212B1 - 발광성 기질을 안정화시키기 위한 조성물 및 방법 - Google Patents

발광성 기질을 안정화시키기 위한 조성물 및 방법 Download PDF

Info

Publication number
KR102456212B1
KR102456212B1 KR1020167033229A KR20167033229A KR102456212B1 KR 102456212 B1 KR102456212 B1 KR 102456212B1 KR 1020167033229 A KR1020167033229 A KR 1020167033229A KR 20167033229 A KR20167033229 A KR 20167033229A KR 102456212 B1 KR102456212 B1 KR 102456212B1
Authority
KR
South Korea
Prior art keywords
composition
att
tak
alkyl
triazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167033229A
Other languages
English (en)
Korean (ko)
Other versions
KR20170012271A (ko
Inventor
토마스 커클랜드
키스 브이. 우드
메리 홀
마리 스윈
Original Assignee
프로메가 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로메가 코포레이션 filed Critical 프로메가 코포레이션
Publication of KR20170012271A publication Critical patent/KR20170012271A/ko
Application granted granted Critical
Publication of KR102456212B1 publication Critical patent/KR102456212B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1007—Non-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Electroluminescent Light Sources (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020167033229A 2014-05-23 2015-05-26 발광성 기질을 안정화시키기 위한 조성물 및 방법 Active KR102456212B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462002363P 2014-05-23 2014-05-23
US62/002,363 2014-05-23
PCT/US2015/032439 WO2015179864A1 (en) 2014-05-23 2015-05-26 Compositions and methods for stabilizing luminogenic substrates

Publications (2)

Publication Number Publication Date
KR20170012271A KR20170012271A (ko) 2017-02-02
KR102456212B1 true KR102456212B1 (ko) 2022-10-20

Family

ID=53434457

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167033229A Active KR102456212B1 (ko) 2014-05-23 2015-05-26 발광성 기질을 안정화시키기 위한 조성물 및 방법

Country Status (10)

Country Link
US (1) US9676997B2 (enExample)
EP (1) EP3146066B1 (enExample)
JP (1) JP6641297B2 (enExample)
KR (1) KR102456212B1 (enExample)
CN (1) CN106661028B (enExample)
AU (1) AU2015263901B2 (enExample)
BR (1) BR112016027504B1 (enExample)
CA (1) CA2949447C (enExample)
SG (1) SG11201609382WA (enExample)
WO (1) WO2015179864A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3661932B1 (en) 2017-08-04 2021-10-06 Promega Corporation Compositions and methods for stabilizing benzothiazole luciferin analogs
IL318819A (en) 2018-10-03 2025-04-01 Promega Corp Compounds and methods for stabilizing cholinetyrazine and its derivatives
CN111116594B (zh) * 2019-12-03 2021-05-28 山东大学 一种C-6位改造NanoLuc类型类似物及其制备方法与应用
CN121399275A (zh) * 2024-05-21 2026-01-23 深圳琅技生命科技有限公司 用于稳定腔肠素及其类似物的组合物及方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008026298A (ja) * 2006-07-24 2008-02-07 National Institute Of Advanced Industrial & Technology ハイスループット発光活性測定のためのセレンテラジン（ウミシイタケルシフェリン）溶液の安定化組成物および安定化法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2000622A1 (de) * 1970-01-08 1971-07-22 Agfa Gevaert Ag Verfahren zur Stabilisierung von Silberbildern
JP4639904B2 (ja) * 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
US7718389B2 (en) * 2006-07-24 2010-05-18 National Institute Of Advanced Industrial Science And Technology Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity
EP2626703B1 (en) * 2008-03-27 2017-05-03 Promega Corporation Protein labeling with cyanobenzothiazole conjugates
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008026298A (ja) * 2006-07-24 2008-02-07 National Institute Of Advanced Industrial & Technology ハイスループット発光活性測定のためのセレンテラジン（ウミシイタケルシフェリン）溶液の安定化組成物および安定化法

Also Published As

Publication number Publication date
EP3146066B1 (en) 2018-03-14
WO2015179864A1 (en) 2015-11-26
BR112016027504A2 (enExample) 2017-08-15
SG11201609382WA (en) 2016-12-29
AU2015263901A1 (en) 2016-11-24
JP2017519977A (ja) 2017-07-20
US20150337198A1 (en) 2015-11-26
BR112016027504B1 (pt) 2023-04-18
CN106661028B (zh) 2021-08-06
US9676997B2 (en) 2017-06-13
CA2949447A1 (en) 2015-11-26
EP3146066A1 (en) 2017-03-29
AU2015263901B2 (en) 2021-03-11
JP6641297B2 (ja) 2020-02-05
CA2949447C (en) 2022-10-04
CN106661028A (zh) 2017-05-10
KR20170012271A (ko) 2017-02-02

Similar Documents

Publication Publication Date Title
Clifford et al. G2 arrest in response to topoisomerase II inhibitors: the role of p53
KR20170012271A (ko) 발광성 기질을 안정화시키기 위한 조성물 및 방법
Alswah et al. Synthesis and Biological Evaluation of Some [1, 2, 4] Triazolo [4, 3‐a] quinoxaline Derivatives as Novel Anticonvulsant Agents
Shah et al. 1, 3‐Oxazole‐isoniazid hybrids: Synthesis, antitubercular activity, and their docking studies
Dhonnar et al. PEG-mediated synthesis, antibacterial, antifungal and antioxidant studies of some new 1, 3, 5-trisubstituted 2-pyrazolines
Akunuri et al. Synthesis and antibacterial evaluation of rhodanine and its related heterocyclic compounds against S. aureus and A. baumannii
Hosamani et al. Synthesis of 2‐mercaptobenzimidazole derivatives as potential anti‐microbial and cytotoxic agents
JP7350713B2 (ja) ベンゾチアゾールルシフェリンアナログを安定化させるための組成物及び方法
Hamama et al. Synthesis of Some New Fused and Binary 1, 3, 4‐Thiadiazoles as Potential Antitumor and Antioxidant Agents
Reddy et al. Synthesis and antimicrobial activity of pyrazolyl benzoxazoles, benzothiazoles and benzimidazoles
Fadda et al. Antimicrobial properties of some new synthesized benzothiazole linked carboxamide, acetohydrazide, and sulfonamide systems
Farghaly et al. Synthesis of New PMB‐Substituted Indoles Containing 1, 3, 4‐Oxadiazole and 1, 2, 4‐Triazole Units
Mandal et al. Synthesis and antitubercular activity of some triazole derivatives of propyl gallate
Rudenko et al. Reactions of N‐arylmaleimides with 3‐amino‐1, 2, 4‐triazole and 2‐aminobenzimidazole
Sari et al. Some new hydrazone derivatives bearing the 1, 2, 4-triazole moiety as potential antimycobacterial agents
Popiołek et al. Synthesis and in Vitro Antimicrobial Activity Screening of New 3‐Acetyl‐2, 5‐disubstituted‐1, 3, 4‐oxadiazoline Derivatives
EL-Hashash et al. Synthesis and Antimicrobial Activity of Some Novel Heterocyclic Candidates via Michael Addition Involving 4‐(4‐Acetamidophenyl)‐4‐oxobut‐2‐enoic Acid
Joshi Antimicrobial Activity of 1, 3, 4-Oxadiazoles: a Review
Choudhare et al. Synthesis and microbial screening of 8‐(benzyloxy)‐5‐(2‐[1, 3‐diphenyl‐1 H‐pyrazol‐4‐yl] thiazol‐4‐yl) quinolin‐2 (1 H)‐one derivatives
Wang et al. Synthesis and Biological Activities of Some Novel (E)‐Alpha‐(methoxyimino) benzeneacetate Derivatives with Modified 1, 2, 4‐Triazole Moiety
Reddy et al. Synthesis and antimicrobial activity of linked heterocyclics containing pyrazole and oxadiazoles
Nikose et al. Synthesis and Biological Evaluation of 2-Substituted-Aryl-3-Substituted-Phenyl-Oxazole-4-Thiazo-lidines as Cyline-Dependent Protein Kinase 2 (CDK2) Inhibitors
Farghaly et al. Regio‐and Site Selectivity in the Reactions of Hydrazonoyl Chlorides with 3‐substituted Indolin‐2‐one Derivatives
Peta et al. Synthesis, characterization and in-vitro anti-microbial activity of substituted 1, 3, 4-thiadiazole derivatives
Nadaraj et al. Synthesis and characterization of condensed pyrazole derivative

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4